Chinese Medicinal Component Relieves CIPN and Mitochondria Function

Stopped Initial prep showed that formulation, QC, and cost for high-dose paeonol/Cortex Moutan exceeded the budget. Also, recruiting patients with chemotherapy-induced peripheral neuropathy was limited. To ensure safety, enrollment did not officially launch.

Conditions

• Breast Cancer
• Chemotherapy-induced Peripheral Neuropathy (CIPN)

Interventions

• DRUG: Moutan cortex
• DRUG: sham moutan cortex

Sponsor

Taiwan Municipal An-Nan Hospital-China Medical University

Collaborators

• [object Object]